FR12C0005I2 - Use of an estrogen-progestogen composition as an oral contraceptive - Google Patents

Use of an estrogen-progestogen composition as an oral contraceptive

Info

Publication number: FR12C0005I2
Authority: FR; France
Prior art keywords: estrogen; oral contraceptive; progestogen composition; progestogen; composition
Prior art date: 1996-10-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR12C0005C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Laboratoire Theramex SAM

Original Assignee

Laboratoire Theramex SAM

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-08

Filing date

2012-01-19

Publication date

2016-06-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9496456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR12C0005(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-01-19 Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM

2012-02-24 Publication of FR12C0005I1 publication Critical patent/FR12C0005I1/en

2016-06-24 Application granted granted Critical

2016-06-24 Publication of FR12C0005I2 publication Critical patent/FR12C0005I2/en

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Orthopedics, Nursing, And Contraception (AREA)

FR12C0005C 1996-10-08 2012-01-19 Use of an estrogen-progestogen composition as an oral contraceptive Active FR12C0005I2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9612239A FR2754179B1 (en)	1996-10-08	1996-10-08	NOVEL HORMONONAL COMPOSITION AND ITS USE
EP97944940A EP0956022B1 (en)	1996-10-08	1997-10-08	Hormonal composition consisting of an oestrogen compound and of a progestational compound

Publications (2)

Publication Number	Publication Date
FR12C0005I1 FR12C0005I1 (en)	2012-02-24
FR12C0005I2 true FR12C0005I2 (en)	2016-06-24

Family

ID=9496456

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FR9612239A Expired - Fee Related FR2754179B1 (en)	1996-10-08	1996-10-08	NOVEL HORMONONAL COMPOSITION AND ITS USE
FR12C0005C Active FR12C0005I2 (en)	1996-10-08	2012-01-19	Use of an estrogen-progestogen composition as an oral contraceptive

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
FR9612239A Expired - Fee Related FR2754179B1 (en)	1996-10-08	1996-10-08	NOVEL HORMONONAL COMPOSITION AND ITS USE

Country Status (38)

Country	Link
US (4)	US6831073B1 (en)
EP (2)	EP1334725B1 (en)
JP (1)	JP4883542B2 (en)
KR (2)	KR100782638B1 (en)
CN (3)	CN104706641A (en)
AP (1)	AP1171A (en)
AR (2)	AR009113A1 (en)
AT (2)	ATE238057T1 (en)
AU (1)	AU745571B2 (en)
BR (1)	BR9712274A (en)
CA (1)	CA2268358C (en)
CL (1)	CL2011000017A1 (en)
CZ (1)	CZ298402B6 (en)
DE (3)	DE69737373T2 (en)
DK (2)	DK0956022T3 (en)
DZ (1)	DZ2327A1 (en)
ES (2)	ES2198006T3 (en)
FR (2)	FR2754179B1 (en)
HK (1)	HK1210708A1 (en)
HU (2)	HU227450B1 (en)
ID (1)	ID21569A (en)
IL (1)	IL129194A (en)
LU (1)	LU91932I2 (en)
MA (1)	MA24370A1 (en)
MY (1)	MY128482A (en)
NO (3)	NO324357B1 (en)
NZ (1)	NZ334876A (en)
OA (1)	OA11033A (en)
PL (1)	PL192979B1 (en)
PT (2)	PT1334725E (en)
RU (1)	RU2274450C2 (en)
SK (2)	SK285056B6 (en)
TN (1)	TNSN97164A1 (en)
TR (1)	TR199900764T2 (en)
TW (1)	TW491704B (en)
WO (1)	WO1998015279A1 (en)
YU (1)	YU18099A (en)
ZA (1)	ZA979011B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4344462C2 (en)	1993-12-22	1996-02-01	Schering Ag	Composition for contraception
DE19549264A1 (en) *	1995-12-23	1997-06-26	Schering Ag	Contraception procedure and kit
FR2754179B1 (en)	1996-10-08	1998-12-24	Theramex	NOVEL HORMONONAL COMPOSITION AND ITS USE
WO2001030355A1 (en) *	1999-10-25	2001-05-03	Laboratoire Theramex	Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
WO2001030356A1 (en) *	1999-10-25	2001-05-03	Laboratoire Theramex	Hormonal composition based on a progestational agent and an oestrogen and use thereof
FR2814074B1 (en) *	2000-09-15	2003-03-07	Theramex	NOVEL TOPICAL ESTRO-PROGESTIVE COMPOSITIONS WITH SYSTEMIC EFFECT
FR2823976A1 (en) *	2001-04-25	2002-10-31	Theramex	NOVEL HORMONAL COMPOSITION AND ITS USE
GT200500315A (en) *	2004-11-02	2006-06-06		SOLID ORAL DOSAGE FORMS CONTAINING A LOW ESTRADIOL DOSE
US20080242650A1 (en) *	2007-03-26	2008-10-02	Jean-Louis Thomas	Oral contraceptive regimen
US20080293683A1 (en) *	2007-05-24	2008-11-27	University Of Kansas Medical Center	Hormone Replacement Therapy
TW200930343A (en) *	2007-09-21	2009-07-16	Organon Nv	Drug delivery system
US10596103B2 (en)	2013-12-11	2020-03-24	Merek Sharp & Dohme B.V.	Drug delivery system for delivery of anti-virals
US10413504B2 (en)	2013-12-11	2019-09-17	Merck Sharp & Dohme Corp.	Intravaginal ring drug delivery system
KR102744791B1 (en)	2022-07-05	2024-12-19	주식회사 이음정보	System For Trading and Managing Patent

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3271392A (en) *	1965-09-14	1966-09-06	American Home Prod	17alpha-[3'-furyl]-estrogens
US4390531A (en)	1981-08-10	1983-06-28	Syntex Pharmaceuticals International Ltd.	Method of contraception using peak progestogen dosage
US4921843A (en)	1988-10-20	1990-05-01	Pasquale Samuel A	Contraception system and method
US4826831A (en) *	1983-08-05	1989-05-02	Pre Jay Holdings Limited	Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4628051A (en) *	1983-09-26	1986-12-09	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
JPS61243059A (en) *	1985-04-19	1986-10-29	Konishi Kagaku Kogyo Kk	Production of high-purity 4-4'-dihydroxydiphenyl-sulfone
US5208225A (en) *	1986-02-27	1993-05-04	Warner-Lambert Company	Compositions containing fixed combinations
ZA87332B (en)	1986-02-27	1987-08-26	Warner Lambert Co	Compositions containing fixed combinations
IE61236B1 (en)	1986-07-15	1994-10-19	American Home Prod	Combination dosage form for pre-menopausal women
US5108995A (en) *	1987-09-24	1992-04-28	Jencap Research Ltd.	Hormone preparation and method
US5256421A (en) *	1987-09-24	1993-10-26	Jencap Research Ltd.	Hormone preparation and method
US5276022A (en) *	1987-09-24	1994-01-04	Jencap Research Ltd.	Hormone preparation and method
CA1332227C (en)	1987-09-24	1994-10-04	Robert F. Casper	Oral contraceptive formulation
DE3888269T2 (en) *	1987-09-24	1994-07-07	Jencap Research Ltd	Hormone composition and application.
HUT52382A (en)	1988-03-14	1990-07-28	Sandoz Ag	Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en)	1990-12-13	1997-02-12	Akzo Nv	Low estrogen oral contraceptives
IE62665B1 (en)	1990-12-17	1995-02-22	Akzo Nv	Contraceptive regimen
FR2695826B1 (en) *	1992-09-21	1995-01-06	Theramex	New pharmaceutical compositions based on nomegestrol derivatives and methods for obtaining them.
US6150343A (en)	1993-06-30	2000-11-21	University Of Pittsburgh	Camptothecin analogs and methods of preparation thereof
US5554601A (en) *	1993-11-05	1996-09-10	University Of Florida	Methods for neuroprotection
DE4344462C2 (en) *	1993-12-22	1996-02-01	Schering Ag	Composition for contraception
US5552394A (en) *	1994-07-22	1996-09-03	The Medical College Of Hampton Roads	Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en)	1994-09-22	2003-09-02	Board Of Regents, The University Of Texas System	Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (en)	1994-10-06	1994-10-06	Astra Ab	Pharmaceutical composition containing derivatives of sex hormones
FR2737411B1 (en)	1995-08-01	1997-10-17	Theramex	NOVEL HORMONAL DRUGS AND THEIR USE FOR CORRECTING ESTROGENIC DEFICIENCIES
DE19540253C2 (en)	1995-10-28	1998-06-04	Jenapharm Gmbh	Multi-phase preparation for contraception based on natural estrogens
DE19549264A1 (en)	1995-12-23	1997-06-26	Schering Ag	Contraception procedure and kit
WO1997041869A1 (en)	1996-05-08	1997-11-13	American Home Products Corporation	Oral contraceptive
AU2815897A (en)	1996-05-08	1997-11-26	American Home Products Corporation	Oral contraceptive
WO1997041870A1 (en)	1996-05-08	1997-11-13	American Home Products Corporation	Oral contraceptive
AU2746097A (en)	1996-05-08	1997-11-26	American Home Products Corporation	Oral contraceptive
WO1997041871A1 (en)	1996-05-08	1997-11-13	American Home Products Corporation	Oral contraceptive
JP2000515889A (en)	1996-07-26	2000-11-28	アメリカン・ホーム・プロダクツ・コーポレイション	Biphasic contraceptive method and kit comprising a mixture of progestin and estrogen
AU3961697A (en)	1996-07-26	1998-02-20	American Home Products Corporation	Oral contraceptive
US5888543A (en) *	1996-07-26	1999-03-30	American Home Products Corporation	Oral contraceptives
WO1998004267A1 (en)	1996-07-26	1998-02-05	American Home Products Corporation	Progestin/estrogen oral contraceptive
BR9710565A (en)	1996-07-26	1999-08-17	American Home Prod	Oral contraceptive
WO1998004246A2 (en)	1996-07-26	1998-02-05	American Home Prod	Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
FR2754179B1 (en) *	1996-10-08	1998-12-24	Theramex	NOVEL HORMONONAL COMPOSITION AND ITS USE
WO2001030355A1 (en)	1999-10-25	2001-05-03	Laboratoire Theramex	Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
DE19705229C2 (en)	1997-02-12	1999-04-15	Hesch Rolf Dieter Prof Dr Med	Use of three hormonal components for hormonal contraception for the treatment and / or prophylaxis of tumors of the mammary glands
US5898032A (en)	1997-06-23	1999-04-27	Medical College Of Hampton Roads	Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DK1007052T3 (en)	1997-08-27	2005-01-31	Ortho Mcneil Pharm Inc	Combinations of endometrically sparing progesterones and endometrial atrophizing progesterones with estrogens in oral contraception
DE19739916C2 (en)	1997-09-11	2001-09-13	Hesch Rolf Dieter	Use of a combination of a progestogen and an estrogen for the continuous inhibition of ovulation and possibly simultaneous treatment and / or prophylaxis of tumors of the mammary glands
AU759925B2 (en)	1997-09-12	2003-05-01	Wyeth	Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
WO2001030356A1 (en)	1999-10-25	2001-05-03	Laboratoire Theramex	Hormonal composition based on a progestational agent and an oestrogen and use thereof

1996
- 1996-10-08 FR FR9612239A patent/FR2754179B1/en not_active Expired - Fee Related
1997
- 1997-10-07 TN TNTNSN97164A patent/TNSN97164A1/en unknown
- 1997-10-08 ZA ZA9709011A patent/ZA979011B/en unknown
- 1997-10-08 AP APAP/P/1999/001500A patent/AP1171A/en active
- 1997-10-08 DK DK97944940T patent/DK0956022T3/en active
- 1997-10-08 YU YU18099A patent/YU18099A/en unknown
- 1997-10-08 RU RU2003107072/15A patent/RU2274450C2/en active
- 1997-10-08 CZ CZ0112099A patent/CZ298402B6/en not_active IP Right Cessation
- 1997-10-08 MA MA24828A patent/MA24370A1/en unknown
- 1997-10-08 US US09/284,147 patent/US6831073B1/en not_active Expired - Lifetime
- 1997-10-08 DK DK03008979T patent/DK1334725T3/en active
- 1997-10-08 DZ DZ970177A patent/DZ2327A1/en active
- 1997-10-08 MY MYPI97004717A patent/MY128482A/en unknown
- 1997-10-08 CN CN201510024865.6A patent/CN104706641A/en active Pending
- 1997-10-08 AT AT97944940T patent/ATE238057T1/en active
- 1997-10-08 AU AU46273/97A patent/AU745571B2/en not_active Expired
- 1997-10-08 ES ES97944940T patent/ES2198006T3/en not_active Expired - Lifetime
- 1997-10-08 HU HU9904508A patent/HU227450B1/en active Protection Beyond IP Right Term
- 1997-10-08 AT AT03008979T patent/ATE353652T1/en active
- 1997-10-08 TR TR1999/00764T patent/TR199900764T2/en unknown
- 1997-10-08 KR KR1020067013702A patent/KR100782638B1/en not_active IP Right Cessation
- 1997-10-08 ES ES03008979T patent/ES2282539T3/en not_active Expired - Lifetime
- 1997-10-08 IL IL12919497A patent/IL129194A/en not_active IP Right Cessation
- 1997-10-08 DE DE69737373T patent/DE69737373T2/en not_active Expired - Lifetime
- 1997-10-08 SK SK438-99A patent/SK285056B6/en not_active IP Right Cessation
- 1997-10-08 KR KR1019990703032A patent/KR20000048981A/en not_active IP Right Cessation
- 1997-10-08 PT PT03008979T patent/PT1334725E/en unknown
- 1997-10-08 EP EP03008979A patent/EP1334725B1/en not_active Expired - Lifetime
- 1997-10-08 PL PL332610A patent/PL192979B1/en unknown
- 1997-10-08 CN CNA2007101694575A patent/CN101229173A/en active Pending
- 1997-10-08 SK SK5098-2005A patent/SK285455B6/en active Protection Beyond IP Right Term
- 1997-10-08 JP JP51726398A patent/JP4883542B2/en not_active Expired - Lifetime
- 1997-10-08 CN CN97180380A patent/CN1239893A/en active Pending
- 1997-10-08 AR ARP970104638A patent/AR009113A1/en not_active Application Discontinuation
- 1997-10-08 EP EP97944940A patent/EP0956022B1/en not_active Expired - Lifetime
- 1997-10-08 ID IDW990211A patent/ID21569A/en unknown
- 1997-10-08 CA CA2268358A patent/CA2268358C/en not_active Expired - Lifetime
- 1997-10-08 BR BR9712274-2A patent/BR9712274A/en not_active Application Discontinuation
- 1997-10-08 WO PCT/FR1997/001792 patent/WO1998015279A1/en active IP Right Grant
- 1997-10-08 NZ NZ334876A patent/NZ334876A/en not_active IP Right Cessation
- 1997-10-08 DE DE69721314T patent/DE69721314T2/en not_active Expired - Lifetime
- 1997-10-08 PT PT97944940T patent/PT956022E/en unknown
- 1997-10-15 TW TW086115281A patent/TW491704B/en not_active IP Right Cessation
1999
- 1999-03-31 NO NO19991593A patent/NO324357B1/en not_active IP Right Cessation
- 1999-04-08 OA OA9900078A patent/OA11033A/en unknown
- 1999-10-25 US US09/423,108 patent/US6906049B1/en not_active Expired - Lifetime
2004
- 2004-01-08 US US10/753,073 patent/US20040220163A1/en not_active Abandoned
2007
- 2007-01-03 US US11/649,672 patent/US7749987B2/en not_active Expired - Fee Related
2009
- 2009-10-26 AR ARP090104109A patent/AR073972A2/en not_active Application Discontinuation
2011
- 2011-01-06 CL CL2011000017A patent/CL2011000017A1/en unknown
2012
- 2012-01-13 LU LU91932C patent/LU91932I2/en unknown
- 2012-01-19 FR FR12C0005C patent/FR12C0005I2/en active Active
- 2012-01-23 DE DE201212000010 patent/DE122012000010I1/en active Pending
- 2012-01-24 NO NO2012002C patent/NO2012002I2/en not_active IP Right Cessation
- 2012-01-26 HU HUS1200002C patent/HUS1200002I1/en unknown
2015
- 2015-11-24 HK HK15111561.9A patent/HK1210708A1/en unknown
2017
- 2017-08-08 NO NO2017043C patent/NO2017043I2/en unknown

Also Published As

Publication number	Publication date
DZ2327A1 (en)	2002-12-28
DE69737373T2 (en)	2007-06-21
ES2198006T3 (en)	2004-01-16
PL332610A1 (en)	1999-09-27
DE69721314T2 (en)	2004-02-12
KR20060084864A (en)	2006-07-25
KR100782638B1 (en)	2007-12-06
FR12C0005I1 (en)	2012-02-24
HU227450B1 (en)	2011-06-28
NZ334876A (en)	2001-06-29
RU2274450C2 (en)	2006-04-20
LU91932I2 (en)	2012-03-13
CN104706641A (en)	2015-06-17
TNSN97164A1 (en)	1999-12-31
SK285056B6 (en)	2006-05-04
MY128482A (en)	2007-02-28
ATE353652T1 (en)	2007-03-15
AU745571B2 (en)	2002-03-21
DE122012000010I1 (en)	2012-04-19
HUP9904508A2 (en)	2000-06-28
HUS1200002I1 (en)	2016-08-29
OA11033A (en)	2003-03-06
US20040220163A1 (en)	2004-11-04
PT956022E (en)	2003-07-31
US20070281912A1 (en)	2007-12-06
CA2268358A1 (en)	1998-04-16
EP0956022A1 (en)	1999-11-17
DE69737373D1 (en)	2007-03-29
ID21569A (en)	1999-06-24
BR9712274A (en)	1999-08-31
US6906049B1 (en)	2005-06-14
WO1998015279A1 (en)	1998-04-16
SK43899A3 (en)	1999-12-10
CA2268358C (en)	2010-04-20
CN1239893A (en)	1999-12-29
FR2754179B1 (en)	1998-12-24
NO991593L (en)	1999-06-07
CZ298402B6 (en)	2007-09-19
PL192979B1 (en)	2006-12-29
JP4883542B2 (en)	2012-02-22
IL129194A0 (en)	2000-02-17
SK285455B6 (en)	2007-01-04
NO2012002I2 (en)	2013-04-02
DE69721314D1 (en)	2003-05-28
ZA979011B (en)	1998-06-03
PT1334725E (en)	2007-05-31
NO324357B1 (en)	2007-10-01
CN101229173A (en)	2008-07-30
DK0956022T3 (en)	2003-08-04
IL129194A (en)	2003-06-24
EP1334725A2 (en)	2003-08-13
CL2011000017A1 (en)	2011-06-24
HK1210708A1 (en)	2016-05-06
ATE238057T1 (en)	2003-05-15
EP1334725A3 (en)	2004-01-21
TR199900764T2 (en)	1999-07-21
DK1334725T3 (en)	2007-06-11
MA24370A1 (en)	1998-07-01
US6831073B1 (en)	2004-12-14
NO2017043I2 (en)	2019-01-25
JP2002509524A (en)	2002-03-26
AR073972A2 (en)	2010-12-15
ES2282539T3 (en)	2007-10-16
AP9901500A0 (en)	1999-06-30
NO2017043I1 (en)	2017-08-08
AU4627397A (en)	1998-05-05
US7749987B2 (en)	2010-07-06
NO991593D0 (en)	1999-03-31
EP0956022B1 (en)	2003-04-23
EP1334725B1 (en)	2007-02-14
AP1171A (en)	2003-06-30
AR009113A1 (en)	2000-03-08
TW491704B (en)	2002-06-21
NO2012002I1 (en)	2012-01-24
HUP9904508A3 (en)	2001-01-29
LU91932I9 (en)	2018-12-27
CZ9901120A3 (en)	2000-11-15
KR20000048981A (en)	2000-07-25
YU18099A (en)	2002-03-18
FR2754179A1 (en)	1998-04-10

Publication	Publication Date	Title
FR12C0005I2 (en)	2016-06-24	Use of an estrogen-progestogen composition as an oral contraceptive
DE19681287T1 (en)	1998-03-19	Oral formulation of 2-methylthienobenzodiazepine
FI963421A0 (en)	1996-09-02	Oral auxiliary compositions
ATE304359T1 (en)	2005-09-15	ANTESTROGEN AND PROGESTIN CONTAINING ORAL CONTRACEPTIVES
FR2726906B1 (en)	1997-08-29	INSTRUMENT OF INDICATION
PT1014987E (en)	2004-06-30	ORAL COMPOSITIONS OF LEVOSIMENDANO
BR9612555A (en)	1999-07-20	Detergent compositions containing fragrance precursors and the fragrance precursors of these compositions
PT906101E (en)	2002-09-30	FORMULATIONS OF PROLONGED LIBERATION CONTAINING MIZOLASTIN
DE59709372D1 (en)	2003-04-03	Fragrance compositions containing substituted 2-acetylbenzofurans
DE69528771D1 (en)	2002-12-12	IMIDAZOLINE COMPOSITIONS CONTAINING SILICON
ID17419A (en)	1997-12-24	COMPOSITION OF DEKAFLUOROPENTANA
FR2756310B1 (en)	1999-01-15	AUXILIARY AMOUNT OF SCAFFOLDING
MD249F1 (en)	1995-07-31	Composition of ingredients for "night" liqueur
UA25103A (en)	1998-12-25	COMPOSITION OF INGREDIENTS FOR SPECIAL Vodka "ZOLOTE RUSLO"
UA1629S (en)	1997-10-31	SET OF FESTONS "VESNYANKA-5"
UA25803A (en)	1998-12-25	COMPOSITION OF INGREDIENTS OF OLD DOCTOR BALM
UA25802A (en)	1998-12-25	COMPOSITION OF INGREDIENTS OF OLD DOCTOR BALM
UA25801A (en)	1998-12-25	COMPOSITION OF INGREDIENTS OF OLD DOCTOR BALM
UA1693S (en)	1997-12-25	SET OF LABELS "AMOUNTS"
UA1957S (en)	1998-04-30	LABEL OF THE MEDICINAL PREPARATION "ASPARKAM"
UA1951S (en)	1998-04-30	LABEL OF THE MEDICINAL PREPARATION "VALIDOL"
UA2094S (en)	1998-06-30	LABEL OF THE MEDICINAL PREPARATION "ASPARKAM"
UA1719S (en)	1997-12-25	SET OF LABELS FOR "BANKETNA" VODKA
UA1879S (en)	1998-04-30	SET OF LABELS FOR "STARORUSKA" VODKA
UA1496S (en)	1997-06-30	SET OF LABELS "ZUBROVKA"